This review article, “Patient Compliance and Medical Research: Issues in Methodology,” by Joy Melnikow and C. Tarina Kiefe, published in the Journal of General Internal Medicine in February 1994, offers a detailed examination of the methodological challenges associated with patient compliance in the realm of medical intervention research. The authors highlight that patient compliance, defined as “The extent to which a person’s behavior . . . coincides with medical advice,” is a constant challenge for physicians and a critical consideration for researchers in the design and analysis of clinical trials.
The core purpose of this review is to introduce readers to these methodologic issues, rather than to provide a systematic synthesis of available data. It specifically addresses two crucial aspects of patient adherence: medication compliance and appointment compliance. Melnikow and Kiefe meticulously detail the inherent difficulties in defining and accurately measuring compliance, emphasizing that there is no single “gold standard” method universally applicable for either type of adherence, and each existing method possesses unique limitations. The article provides a comprehensive overview of various measurement techniques, ranging from traditional approaches like patient interviews and pill counts to more objective methods such as serum drug levels and electronic medication dispensers, acknowledging the latter’s emergence as a new standard while also discussing their remaining problems.
Furthermore, the authors underscore the profound impact of compliance on clinical trial design and interpretation. They distinguish between efficacy studies, which evaluate a treatment under ideal circumstances, and effectiveness studies, which assess a treatment under typical medical practice conditions, noting how compliance considerations differ for each. The review explains that lack of compliance can significantly distort research outcomes, potentially leading to an overestimation of therapeutic dosage and subsequent drug toxicity for compliant patients in real-world practice, or requiring vastly increased sample sizes to maintain statistical power. The article also delves into the complex question of whether compliance has an independent effect on outcome, observing that some studies suggest compliant patients experience improved outcomes regardless of whether they received the active drug or a placebo, a finding that introduces further methodological challenges and areas for research. Finally, Melnikow and Kiefe discuss various techniques for enhancing both medication and appointment compliance, including the use of short-term regimens, fewer daily doses, lower medication costs, easy-to-use packaging, reminders, tailoring, and fostering patient satisfaction, though they note that the effectiveness of patient education in this regard remains controversial. This insightful review serves as an essential guide for researchers and consumers of medical literature alike, advocating for careful consideration of how compliance is measured and analyzed when interpreting clinical trial results.
REFERENCE:Melnikow, J., & Kiefe, C. T. (1994). Patient compliance and medical research: Issues in methodology. Journal of General Internal Medicine, 9(2), 96–105.
